BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 35537938)

  • 1. Redefining Rare Genitourinary Cancers: An Initiative Led by the Global Society of Rare Genitourinary Tumors.
    Costa de Padua T; Sabino Marques Monteiro F; Necchi A; Spiess PE
    Eur Urol; 2024 May; 85(5):414-416. PubMed ID: 38403526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genitourinary tumors.
    Herr H; Sogani P; Eastham J
    J Surg Oncol; 2022 Oct; 126(5):926-932. PubMed ID: 36087085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and molecular landscape of genitourinary tumors and clinical implications.
    Sirohi D
    Urol Oncol; 2024 Jul; 42(7):191-192. PubMed ID: 38670817
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel and Emerging Concepts in Genitourinary Tumors Empowered in the Multidisciplinary and Molecular Era.
    Paner GP
    Adv Anat Pathol; 2024 May; 31(3):145-146. PubMed ID: 38512018
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ⅰ. Liquid Biopsy and Urologic Tumors: Overview-Japanese Society for the Study of Liquid Biopsy].
    Okegawa T
    Gan To Kagaku Ryoho; 2024 Jan; 51(1):25-30. PubMed ID: 38247087
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For.
    Salami SS
    Eur Urol Focus; 2022 May; 8(3):637-638. PubMed ID: 35817702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uronephrological and urogenital tumors: the urologist's viewpoint].
    Leisinger HJ
    Rev Med Suisse Romande; 1995 Mar; 115(3):227-8. PubMed ID: 7777761
    [No Abstract]   [Full Text] [Related]  

  • 8. Present and future of personalized medicine in adult genitourinary tumors.
    Ciccarese C; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Conti A; Tortora G; Cascinu S; Montironi R
    Future Oncol; 2015; 11(9):1381-8. PubMed ID: 25952784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of artificial intelligence in urologic oncology.
    Hosein S; Reitblat CR; Cone EB; Trinh QD
    Curr Opin Urol; 2020 Nov; 30(6):748-753. PubMed ID: 32941255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers.
    Abern MR; Dudinec JV; Inman BA
    Eur Urol Focus; 2022 May; 8(3):639-640. PubMed ID: 35537938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving Role of Genomics in Genitourinary Neoplasms.
    Devitt ME; Dreicer R
    Acta Med Acad; 2019 Apr; 48(1):68-77. PubMed ID: 31264434
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.